Tuesday, October 17, 2017
 

 
LOS ANGELES, Oct. 16, 2017 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that Nasdaq has granted the Company's request for a continued listing pending the results of  a stockholder vote on or before Octob.....   [READ MORE]

FORT LAUDERDALE, Fla. (PRWEB) October 14, 2017   [READ MORE]

 
ROCKVILLE, Md., Oct. 13, 2017 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (the "Company") (Nasdaq: CASI), a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on   [READ MORE]
ST. PAUL, Minn., Oct. 12, 2017 /PRNewswire/ -- Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving more than 20 million members nationally, today released mid-year drug trend reports.  The reports reveal positive results for how Prime helped its commercial, Medicare Part D, and Medicaid clients co.....   [READ MORE]
 
RALEIGH, N.C., Oct. 12, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc., .....   [READ MORE]
 
 
MORE NEWS
 
 
 
 
 
 
 
 
 
 
 
 
 





About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines